title: Treating patients with medically resistant epilepsy.
abstract: Recent evidence suggests that medically resistant epilepsy can be identified if seizures persist despite adequate doses of 2 appropriate first-line antiepileptic drugs (AEDs). Patients with medically resistant epilepsy should have their seizures carefully characterized in order to confirm their diagnosis, select treatment, and assist in determining prognosis. Patients should be counseled about factors that aggravate epilepsy and the importance of adhering to treatments. Physicians should carefully inquire about side effects and alter therapy to eliminate or minimize these symptoms. Uncontrolled seizures cause injuries, disability, and increased mortality, so surgery should be considered as soon as seizures are proven to be medically resistant. Patients with incomplete response to AEDs and who are not surgical candidates may benefit from additional medication trials or from palliative nonmedical therapies, such as vagal nerve stimulation.
authors: Johns Hopkins University (GLK), Baltimore; and Thomas Jefferson University (MRS), Philadelphia.
authors: Gregory L
authors: GL
authors: Krauss
authors: Michael R
authors: MR
authors: Sperling
references: Neurology. 2005 Jun 14;64(11):1879-83
references: 15955937
references: Epilepsia. 2009 May;50(5):1158-66
references: 19170737
references: Neurology. 2005 Jun 14;64(11):1868-73
references: 15955935
references: Acta Neurol Scand. 2006 Sep;114(3):157-68
references: 16911343
references: Neurology. 2004 Apr 27;62(8):1252-60
references: 15111659
references: Heart. 2003 Mar;89(3):353-8
references: 12591858
references: Neurotherapeutics. 2009 Apr;6(2):406-14
references: 19332337
references: Eur J Neurol. 2006 Mar;13(3):277-82
references: 16618346
references: N Engl J Med. 2000 Feb 3;342(5):314-9
references: 10660394
references: Brain. 2004 Aug;127(Pt 8):1774-84
references: 15201192
references: Epilepsia. 2011 Aug;52(8):e84-8
references: 21740416
references: Pract Neurol. 2010 Aug;10(4):208-18
references: 20647527
references: Epilepsia. 2011 May;52(5):925-31
references: 21561447
references: Curr Treat Options Neurol. 2011 Aug;13(4):355-70
references: 21494841
references: CNS Spectr. 2004 Feb;9(2):98-101, 106-9
references: 14999166
references: J Am Coll Cardiol. 2002 Jul 3;40(1):142-8
references: 12103268
references: Neurology. 2004 Mar 9;62(5 Suppl 2):S24-9
references: 15007161
references: N Engl J Med. 2001 Aug 2;345(5):311-8
references: 11484687
references: Clin Neuropharmacol. 2008 Nov-Dec;31(6):333-8
references: 19050410
references: Neurology. 1994 Aug;44(8):1403-7
references: 8058138
references: Epilepsia. 2005;46 Suppl 11:49-53
references: 16393181
references: J Neurosurg. 2011 Dec;115(6):1248-55
references: 21838505
references: Epilepsy Behav. 2008 May;12(4):557-71
references: 18158270
references: Lancet. 2007 Mar 24;369(9566):1000-15
references: 17382827
references: Epilepsia. 2004;45 Suppl 6:28-34
references: 15315513
references: Brain. 2009 Oct;132(Pt 10):2630-42
references: 19587129
references: J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):75-9
references: 14707312
references: Epilepsy Behav. 2008 Aug;13(2):271-8
references: 18539083
references: Epilepsia. 1996 Feb;37(2):148-61
references: 8635425
references: Ann Neurol. 2011 Jun;69(6):997-1004
references: 21437930
references: Epilepsia. 2010 Jun;51(6):1069-77
references: 19889013
references: Ann Intern Med. 1991 Dec 1;115(11):871-6
references: 1952474
references: Neurology. 2007 May 15;68(20):1701-9
references: 17502552
references: Lancet. 2007 Mar 24;369(9566):1016-26
references: 17382828